NTAL_HUMAN - dbPTM
NTAL_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NTAL_HUMAN
UniProt AC Q9GZY6
Protein Name Linker for activation of T-cells family member 2
Gene Name LAT2
Organism Homo sapiens (Human).
Sequence Length 243
Subcellular Localization Cell membrane
Single-pass type III membrane protein . Present in lipid rafts.
Protein Description Involved in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. May also be involved in BCR (B-cell antigen receptor)-mediated signaling in B-cells and FCGR1 (high affinity immunoglobulin gamma Fc receptor I)-mediated signaling in myeloid cells. Couples activation of these receptors and their associated kinases with distal intracellular events through the recruitment of GRB2..
Protein Sequence MSSGTELLWPGAALLVLLGVAASLCVRCSRPGAKRSEKIYQQRSLREDQQSFTGSRTYSLVGQAWPGPLADMAPTRKDKLLQFYPSLEDPASSRYQNFSKGSRHGSEEAYIDPIAMEYYNWGRFSKPPEDDDANSYENVLICKQKTTETGAQQEGIGGLCRGDLSLSLALKTGPTSGLCPSASPEEDEESEDYQNSASIHQWRESRKVMGQLQREASPGPVGSPDEEDGEPDYVNGEVAATEA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
23PhosphorylationVLLGVAASLCVRCSR
HHHHHHHHHHHHCCC
16.7424719451
25S-palmitoylationLGVAASLCVRCSRPG
HHHHHHHHHHCCCCC
1.3512486104
28S-palmitoylationAASLCVRCSRPGAKR
HHHHHHHCCCCCCCH
1.7012486104
38UbiquitinationPGAKRSEKIYQQRSL
CCCCHHHHHHHHHCH
48.2125015289
40PhosphorylationAKRSEKIYQQRSLRE
CCHHHHHHHHHCHHH
15.0617993265
44PhosphorylationEKIYQQRSLREDQQS
HHHHHHHCHHHHHHH
27.6923401153
51PhosphorylationSLREDQQSFTGSRTY
CHHHHHHHHHCCCEE
21.1023401153
53PhosphorylationREDQQSFTGSRTYSL
HHHHHHHHCCCEEEE
39.2230266825
55PhosphorylationDQQSFTGSRTYSLVG
HHHHHHCCCEEEECC
20.5628450419
57PhosphorylationQSFTGSRTYSLVGQA
HHHHCCCEEEECCEE
21.1128450419
58PhosphorylationSFTGSRTYSLVGQAW
HHHCCCEEEECCEEC
10.0117993265
59PhosphorylationFTGSRTYSLVGQAWP
HHCCCEEEECCEECC
18.9023401153
77UbiquitinationADMAPTRKDKLLQFY
HHCCCCCHHHHHHHC
62.7923000965
77 (in isoform 2)Ubiquitination-62.7921890473
77 (in isoform 1)Ubiquitination-62.7921890473
79UbiquitinationMAPTRKDKLLQFYPS
CCCCCHHHHHHHCCC
54.8823000965
79 (in isoform 2)Ubiquitination-54.8821890473
79 (in isoform 1)Ubiquitination-54.8821890473
84PhosphorylationKDKLLQFYPSLEDPA
HHHHHHHCCCCCCCC
4.4829978859
86PhosphorylationKLLQFYPSLEDPASS
HHHHHCCCCCCCCHH
32.7723401153
92PhosphorylationPSLEDPASSRYQNFS
CCCCCCCHHHCCCCC
22.2729523821
93PhosphorylationSLEDPASSRYQNFSK
CCCCCCHHHCCCCCC
36.7929523821
95PhosphorylationEDPASSRYQNFSKGS
CCCCHHHCCCCCCCC
15.1217993265
99PhosphorylationSSRYQNFSKGSRHGS
HHHCCCCCCCCCCCC
43.5924719451
100UbiquitinationSRYQNFSKGSRHGSE
HHCCCCCCCCCCCCC
57.6925015289
102PhosphorylationYQNFSKGSRHGSEEA
CCCCCCCCCCCCCCC
25.4928188228
106PhosphorylationSKGSRHGSEEAYIDP
CCCCCCCCCCCCCCH
26.5823401153
110PhosphorylationRHGSEEAYIDPIAME
CCCCCCCCCCHHHHH
14.7728450419
118PhosphorylationIDPIAMEYYNWGRFS
CCHHHHHHHCCCCCC
6.7630576142
119PhosphorylationDPIAMEYYNWGRFSK
CHHHHHHHCCCCCCC
7.3717993265
125PhosphorylationYYNWGRFSKPPEDDD
HHCCCCCCCCCCCCC
42.7823684312
126UbiquitinationYNWGRFSKPPEDDDA
HCCCCCCCCCCCCCC
62.98-
135PhosphorylationPEDDDANSYENVLIC
CCCCCCCCCCCEEEE
35.2323401153
136PhosphorylationEDDDANSYENVLICK
CCCCCCCCCCEEEEE
16.0112486104
145UbiquitinationNVLICKQKTTETGAQ
CEEEEEEECCCCCCC
42.8025015289
165PhosphorylationGLCRGDLSLSLALKT
CCCCCCEEEEEEECC
22.2030266825
167PhosphorylationCRGDLSLSLALKTGP
CCCCEEEEEEECCCC
14.2823401153
175PhosphorylationLALKTGPTSGLCPSA
EEECCCCCCCCCCCC
36.4530108239
176PhosphorylationALKTGPTSGLCPSAS
EECCCCCCCCCCCCC
32.6630108239
181PhosphorylationPTSGLCPSASPEEDE
CCCCCCCCCCCCCCC
40.1428450419
183PhosphorylationSGLCPSASPEEDEES
CCCCCCCCCCCCCCC
36.8628450419
190PhosphorylationSPEEDEESEDYQNSA
CCCCCCCCHHHCCHH
33.4523401153
193PhosphorylationEDEESEDYQNSASIH
CCCCCHHHCCHHHHH
12.9212486104
196PhosphorylationESEDYQNSASIHQWR
CCHHHCCHHHHHHHH
14.1023401153
198PhosphorylationEDYQNSASIHQWRES
HHHCCHHHHHHHHHH
22.0328450419
205PhosphorylationSIHQWRESRKVMGQL
HHHHHHHHHHHHHHH
28.91-
217PhosphorylationGQLQREASPGPVGSP
HHHHHHCCCCCCCCC
26.1522115753
223PhosphorylationASPGPVGSPDEEDGE
CCCCCCCCCCCCCCC
29.4329052541
233PhosphorylationEEDGEPDYVNGEVAA
CCCCCCCCCCCEEEE
13.4112486104
241PhosphorylationVNGEVAATEA-----
CCCEEEECCC-----
23.7822115753

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
95YPhosphorylationKinaseLYNP07948
PSP
110YPhosphorylationKinaseKITP10721
PSP
110YPhosphorylationKinaseLYNP07948
PSP
118YPhosphorylationKinaseKITP10721
PSP
118YPhosphorylationKinaseLYNP07948
PSP
119YPhosphorylationKinaseLYNP07948
PSP
136YPhosphorylationKinaseSYKP43405
PSP
136YPhosphorylationKinaseLYNP07948
PSP
193YPhosphorylationKinaseSYKP43405
PSP
233YPhosphorylationKinaseSYKP43405
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NTAL_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NTAL_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
GRB2_HUMANGRB2physical
12514734
PLCG1_HUMANPLCG1physical
12514734
PLCG2_HUMANPLCG2physical
12514734

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NTAL_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-135, AND MASSSPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND MASSSPECTROMETRY.
"The importance of three membrane-distal tyrosines in the adaptorprotein NTAL/LAB.";
Koonpaew S., Janssen E., Zhu M., Zhang W.;
J. Biol. Chem. 279:11229-11235(2004).
Cited for: MUTAGENESIS OF TYR-58; TYR-84; TYR-95; TYR-110; TYR-118; TYR-136;TYR-193 AND TYR-233, PHOSPHORYLATION AT TYR-136; TYR-193 AND TYR-233,AND INTERACTION WITH GRB2.
"Non-T cell activation linker (NTAL): a transmembrane adaptor proteininvolved in immunoreceptor signaling.";
Brdicka T., Imrich M., Angelisova P., Brdickova N., Horvath O.,Spicka J., Hilgert I., Luskova P., Draber P., Novak P., Engels N.,Wienands J., Simeoni L., Oesterreicher J., Aguado E., Malissen M.,Schraven B., Horejsi V.;
J. Exp. Med. 196:1617-1626(2002).
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION BY MASSSPECTROMETRY, INTERACTION WITH GRB2; SOS1; GAB1 AND CBL, TISSUESPECIFICITY, PALMITOYLATION AT CYS-25 AND CYS-28, SUBCELLULARLOCATION, PHOSPHORYLATION AT TYR-136; TYR-193 AND TYR-233,UBIQUITINATION, AND FUNCTION.

TOP